GNCA - Genocea Biosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - GNCA (1457612)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
22 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-06-02
GNCADuvall DianthaCFOS - Sale$0.06-1,35575,388-2%-$81
2022-06-02
GNCAFlechtner Jessica BakerChief Scientific OfficerS - Sale$0.06-1,57889,027-2%-$95
2022-06-02
GNCAClark William DPres, CEOS - Sale$0.06-4,023304,377-1%-$241
2022-06-01
GNCASumer Jacquelyn LCHIEF LEGAL, COMPLIANCE OFFS - Sale$0.06-2,50043,000-5%-$150
2022-05-31
GNCAClark William DPres, CEOS - Sale$0.06-117,244308,400-28%-$7,234
2022-05-27
GNCASiber GeorgeDirS - Sale$0.07-20,425252-99%-$1,334
M
2022-05-24
GNCAWalker Paul Edward10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCASonsini Peter W.10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCASandell Scott D10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCANew Enterprise Associates 16, L.P.10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCAMakhzoumi Mohamad10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCAFlorence Anthony A. Jr.10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCAChang Carmen10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCABehbahani AliDir, 10%S - Sale$0.07-10,376,9360-100%-$750,662
M
2022-05-24
GNCABaskett Forest10%S - Sale$0.07-10,376,9360-100%-$750,662
2022-05-25
GNCAFlechtner Jessica BakerChief Scientific OfficerS - Sale$0.09-16,52590,605-15%-$1,456
2022-05-26
GNCADuvall DianthaCFOS - Sale$0.08-24,40776,743-24%-$1,867
2022-04-04
GNCAFlechtner Jessica BakerChief Scientific OfficerS - Sale$1.25-1,21296,193-1%-$1,515
2022-04-04
GNCADuvall DianthaCFOS - Sale$1.25-96391,775-1%-$1,204
2022-04-04
GNCADavis Thomas AndrewCHIEF MEDICAL OFFICERS - Sale$1.25-1,09168,330-2%-$1,364
2022-04-04
GNCAClark William DPres, CEOS - Sale$1.25-3,924369,487-1%-$4,905
2022-04-04
GNCAAakalu Girish NCHIEF BUSINESS OFFICERS - Sale$1.25-96374,459-1%-$1,204

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top